These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 32586688

  • 1. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma.
    Yanai M, Kurata M, Muto Y, Iha H, Kanao T, Tatsuzawa A, Ishibashi S, Ikeda M, Kitagawa M, Yamamoto K.
    Pathology; 2020 Aug; 52(5):529-537. PubMed ID: 32586688
    [Abstract] [Full Text] [Related]

  • 2. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J, Wozniak A, Adams A, Cox J, Vittal A, Voss J, Bridges B, Weinman SA, Li Z.
    J Exp Clin Cancer Res; 2019 Jun 13; 38(1):252. PubMed ID: 31196136
    [Abstract] [Full Text] [Related]

  • 3. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J, Zhang N, Sun H, Su L, Zhang C, Xu H, Feng J, Wang M, Chen J, Liu L, Shan J, Shen J, Yang Z, Wang G, Zhou H, Prieto J, Ávila MA, Liu C, Qian C.
    Gastroenterology; 2020 Feb 13; 158(3):664-678.e24. PubMed ID: 31678303
    [Abstract] [Full Text] [Related]

  • 4. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Park WS, Lee JY, Borlak J, Nam SW.
    Hepatology; 2013 Mar 13; 57(3):1055-67. PubMed ID: 23079745
    [Abstract] [Full Text] [Related]

  • 5. MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24.
    Hu Z, Zhao Y, Mang Y, Zhu J, Yu L, Li L, Ran J.
    Life Sci; 2023 Jul 15; 325():121773. PubMed ID: 37187452
    [Abstract] [Full Text] [Related]

  • 6. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
    Wang W, Jia WD, Hu B, Pan YY.
    Oncotarget; 2017 Apr 18; 8(16):26434-26447. PubMed ID: 28460436
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of circular RNA circPVT1 restricts cell growth of hepatocellular carcinoma through downregulation of Sirtuin 7 via microRNA-3666.
    Li Y, Shi H, Yuan J, Qiao L, Dong L, Wang Y.
    Clin Exp Pharmacol Physiol; 2020 Jul 18; 47(7):1291-1300. PubMed ID: 32017171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL, Shyue SK, Lin LI, Feng ZR, Liou JY, Fan HH, Lee BS, Hsu C, Cheng AL.
    Oncotarget; 2015 Sep 29; 6(29):27953-65. PubMed ID: 26172295
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H, Wang J, Yin J, Lu B, Yang Q, Wan Y, Jia C.
    Cell Physiol Biochem; 2018 Sep 29; 45(3):1121-1135. PubMed ID: 29439259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
    Wu J, Chai H, Li F, Ren Q, Gu Y.
    Life Sci; 2020 Nov 01; 260():118406. PubMed ID: 32918976
    [Abstract] [Full Text] [Related]

  • 15. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
    Fan L, Huang X, Chen J, Zhang K, Gu YH, Sun J, Cui SY.
    Mol Cancer Ther; 2020 May 01; 19(5):1197-1209. PubMed ID: 32220970
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, Song G, Weng S, Dong L, Zhu J, Liu T, Guo C, Shen X.
    J Hepatol; 2020 May 01; 72(5):909-923. PubMed ID: 31899205
    [Abstract] [Full Text] [Related]

  • 19. Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression.
    Wang H, Xu H, Ma F, Zhan M, Yang X, Hua S, Li W, Li Y, Lu L.
    Cell Death Dis; 2020 Apr 08; 11(4):225. PubMed ID: 32269215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.